Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945 A Noninvasive Assessment and Comparison With Atorvastatin

Esad Vucic, Claudia Calcagno, Stephen D. Dickson, James H. F. Rudd, Katsumi Hayashi, Jan Bucerius, Erin Moshier, Jessica S. Mounessa, Michelle Roytman, Matthew J. Moon, James Lin, Sarayu Ramachandran, Tatsuo Tanimoto, Karen Brown, Masakatsu Kotsuma, Sotirios Tsimikas, Edward A. Fisher, Klaas Nicolay, Valentin Fuster, Zahi A. Fayad

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)819-828
JournalJACC-Cardiovascular Imaging
Volume5
Issue number8
DOIs
Publication statusPublished - Aug 2012

Keywords

  • atherosclerosis
  • dynamic contrast-enhanced
  • cardiac magnetic resonance
  • F-18-FDG-PET/CT
  • LXR agonist

Cite this

Vucic, E., Calcagno, C., Dickson, S. D., Rudd, J. H. F., Hayashi, K., Bucerius, J., Moshier, E., Mounessa, J. S., Roytman, M., Moon, M. J., Lin, J., Ramachandran, S., Tanimoto, T., Brown, K., Kotsuma, M., Tsimikas, S., Fisher, E. A., Nicolay, K., Fuster, V., & Fayad, Z. A. (2012). Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945 A Noninvasive Assessment and Comparison With Atorvastatin. JACC-Cardiovascular Imaging, 5(8), 819-828. https://doi.org/10.1016/j.jcmg.2011.11.025